tiprankstipranks
pc:dbiox

D3 Bio

https://www.d3bio.com/
D3 Bio is a global biotechnology company focused on the discovery, development, and registration of new medicines in oncology and immunology. The company's discovery and development platforms leverage proprietary clinical insight and biomarker strategies to create novel and clinically meaningful therapies for patients in need.

Leadership & Board

Current Number of Employees25
Current LinkedIn Followers658

Latest Estimated Valuation

Estimated Valuation
Estimated Valuation
Total Amount Raised$170M
Total Amount Raised$170M
Total Funding Rounds2
Total Funding Rounds2
Latest Funding Amount$108M
Latest Funding Amount$108M
Latest Funding RoundSeries B
Latest Funding RoundSeries B
Post-Money Valuation
Post-Money Valuation

Employee Trend

D3 Bio had 25 employees as of April 27, 2026. The number of employees decreased by 1 (3.85%) week-over-week.
25Latest Employee Count
1(-3.85%)Week-Over-Week Change
Employee Trend serves as a data-driven indicator of company growth and expansion. The measurement reflects how a company’s workforce size changes over time.

Social Trend

D3 Bio had 658 followers as of April 27, 2026. The number of followers increased by 18 (2.81%) week-over-week.
658Latest Followers Count
18(2.81%)Week-Over-Week Change
LinkedIn Follower Trend serves as a data-driven indicator of market interest and company visibility. The measurement reflects how a company’s LinkedIn follower count changes over time.

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Dec 10, 2025
Series B
$108.00M
May 08, 2024
Series A
$62.00M

Investors

Investor Name
Funding Round
Series B
Series B
Series B
Series B
Series B
Series A

Related News and Analysis